Nasim Sheikh-Bahaei, MD, PhD

Associate Professor of Clinical Radiology and Neurology

Medical Director: Radiology – Keck Hospital

Section Chief of Neuroradiology

Image of Nasim Sheikh-Bahaei, MD, PhD
Is this your profile? Click to edit

Overview

Dr. Sheikh-Bahaei is a double board-certified physician in internal medicine and radiology with subspecialty training in neuroradiology. She received her M.D. from Tehran University of Medical Sciences and her PhD on Alzheimer’s disease (AD) imaging from University of Cambridge, U.K. Her PhD was a multimodality imaging study focusing on positron emission tomography (PET), MR spectroscopy (MRS) and susceptibility weighted imaging (SWI) in AD, funded by National Institute for Health Research (NIHR).
Dr. Sheikh-Bahaei’s main research interest is the imaging biomarkers for diagnosis and prognosis of different neurodegenerative diseases and dementias utilizing advanced MRI techniques and PET scans with various tracers for metabolism, amyloid and tau. She is currently a Co-Investigator in the imaging core of Alzheimer’s disease research center (ADRC) at USC and working on different imaging cohorts at Laboratory of Neuroimaging (LONI) and ADRC. Her active research studies are:
• Neurodegenerative diseases including AD, Primary Progressive aphasia and PDD/DLB.
a. Synaptic function in Alzheimer’s disease and its association with amyloid beta and tau proteins.
b. Interaction between the level of different neurotransmitters measured by MRS and function and density of synapses and their relationship with tractography in AD.
c. Development of new tracers for AD and other dementias and optimizing the production of current tracers and improving the quality of PET images and establishing a semi-automated high-quality quantitative PET analysis system.
• The role of microvascular changes (i.e. cerebral microbleeds, perivascular spaces and white matter changes) in different neurological disorders including:
a. Alzheimer’s disease and other dementias: investigating the interaction between vascular changes and proteinopathy in AD. She was involved in developing an automated software for quantification of perivascular spaces at USC and currently working on a new atlas for normal and abnormal distribution of perivascular spaces across the life span.
b. Migraine and other headaches, using 7T MRI to investigate the microvascular changes, perfusion and functional alteration in different types of Migraine.
c. Normal pressure hydrocephalus, Idiopathic intracranial hypertension and Spontaneous intracranial hypotension; investigating the glymphatic system and perivascular spaces and the role of CSF clearance in various disorders associated with CSF flow impairment

Awards

  • Western Neuroradiological Society: Gabriel H Wilson Award, 2018
  • Cambridge University: EG Fearnside Scholarship, 2016
  • Cambridge University Hospitals: Charles Freer Scholarship, 2013

Research Funding

  • Vascular and Connectivity changes in chronic migraines and episodic migraines without aura using ultra high field MRI
    Center for Image Acquisition · Feb 26, 2020 – Feb 26, 2021 · Role: Principal Investogator
  • Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer?s Disease
    NIH · R01AG062007 · Feb 15, 2019 – Nov 30, 2024 · Role: Co-Investigator
  • Alzheimer Disease Research Center
    NIH · 5P50AG005142-35 · Apr 15, 1997 – Mar 31, 2020 · Role: Co-Investigator

Research Keywords

  • Alzheimer’s disease Imaging
  • PET imaging in dementia
  • MR Spectroscopy
  • Microvascular changes (perivascular spaces and cerebral microbleeds) in Alzheimer’s disease
  • Synaptic function in dementia

Publications

  • Traumatic brain injury and post-traumatic stress disorder on brain imaging markers and cognition in a war veterans population. J Alzheimers Dis. 2026 Jul; 112(1):440-451.. View in PubMed
  • Biopsychosocial risk factors for Alzheimer’s disease and related dementias in UK immigrants from the Middle East and North Africa (MENA). medRxiv. 2026 May 13.. View in PubMed
  • A novel mutation in colony-stimulating factor 1 receptor (CSF1R) causing CSF1R-related disorder (CSF1R-RD). Neurocase. 2026 Feb; 32(1):13-21.. View in PubMed
  • The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease. Mol Neurodegener Adv. 2025; 1(1):4.. View in PubMed
  • The Curious Case of a Heterozygous Loss-of-Function PSEN1 variant associated with Early-Onset Alzheimer’s Disease. Res Sq. 2025 Aug 27.. View in PubMed
  • Advancing 1.5T MR imaging: toward achieving 3T quality through deep learning super-resolution techniques. Front Hum Neurosci. 2025; 19:1532395.. View in PubMed
  • Diffusion based multi-domain neuroimaging harmonization method with preservation of anatomical details. Neuroimage. 2025 Aug 01; 316:121297.. View in PubMed
  • Interleaved flow-sensitive dephasing (iFSD): Toward enhanced blood flow suppression and preserved T1 weighting and overall signals in 3D TSE-based neuroimaging. Magn Reson Med. 2025 May; 93(5):1911-1923.. View in PubMed
  • Pearls and Pitfalls of T1-Weighted Neuroimaging: A Primer for the Clinical Radiologist. Acad Radiol. 2025 05; 32(5):2940-2952.. View in PubMed
  • Neuroinflammation modifies the relationship between stress and perivascular spaces in an elderly population with different levels of cognitive impairment. Front Cell Neurosci. 2024; 18:1480405.. View in PubMed